Patent details

EP3972591 Title: PHARMACEUTICAL COMPOSITIONS COMPRISING FLUBENDAZOLE

Basic Information

Publication number:
EP3972591
PCT Application Number:
GB2020051920
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP207605072
PCT Publication Number:
WO2022034275
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOSITIONS COMPRISING FLUBENDAZOLE
French Title of Invention:
COMPOSITIONS PHARMACEUTIQUES COMPRENANT DU FLUBENDAZOLE
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT FLUBENDAZOL
SPC Number:

Dates

Filing date:
12/08/2020
Grant date:
28/12/2022
EP Publication Date:
30/03/2022
PCT Publication Date:
17/02/2022
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/12/2022
EP B1 Publication Date:
28/12/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/08/2023
Expiration date:
12/08/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/12/2022
 
 

Name:
Zephapharm Ltd.
Address:
The Harley Building 77 New Cavendish Street, London W1W 6XB, United Kingdom (GB)

Inventor

Name:
TAYLOR, John.
Address:
United Kingdom (GB)

Classification

IPC classification:
A61K 31/427; A61K 31/522; A61K 31/496; A61K 31/15; A61K 31/404; A61K 31/37; A61K 31/138; A61K 31/4164; A61P 35/00; A61P 31/00; A61P 29/00;

Publication

European Patent Bulletin

Issue number:
202252
Publication date:
28/12/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages